CDH1 and metabolic disease: Probiotics such as Lactobacillus were reported to improve metabolic disorders in a HFD mouse model, which was involved in epithelial barrier function and adherence junction protein expression, including the Notch signaling pathway and E-cadherins (37, –, 39).